Has Quentin Vanmeter received payments from drug or device companies?

Yes. Drug and device makers reported $474,920 in general payments to Quentin Vanmeter across 1,422 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Quentin Vanmeter did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Quentin Vanmeter come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Quentin Vanmeter

Pediatric Endocrinology · Atlanta, GANPI 1245265453

Payments from drug & device makers

$474,920in general payments, 2019–2025

Across 1,422 payments — averaging $333.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$134K
Novo Nordisk AS$107K
Eli Lilly$68K
AbbVie$63K
Sanofi-aventis U.S. LLC$43K
Eton Pharmaceuticals, Inc.$13K
plus $48K from 43 others

$16,785in research payments, 2019–2025

Across 7 payments — averaging $2397.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$15K
Novo Nordisk$1K

What the payments were for

Consulting fees$21,81910%
Speaking & faculty fees$148,26569%
Travel & lodging$23,80511%
Food & beverage$21,01010%
Education$170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	181	$134,059
Novo Nordisk AS	654	$106,515
Eli Lilly	12	$67,756
AbbVie	99	$62,513
Sanofi-aventis U.S. LLC	39	$42,829
Eton Pharmaceuticals, Inc.	6	$12,783
Pfizer	40	$12,755
Mannkind Corporation	7	$5,484
Tolmar Pharmaceuticals, Inc.	13	$5,454
Novo Nordisk Health Care AG	3	$5,448
Azurity Pharmaceuticals, Inc.	29	$5,214
Sanofi US Services Inc.	4	$4,750
AstraZeneca	11	$1,553
Insulet Corporation	45	$866
Xeris Pharmaceuticals, Inc.	41	$721
Ascendis Pharma Endocrinology Inc	22	$605
BETA Bionics, Inc.	10	$558
Sequel Med Tech, LLC	17	$446
Tandem Diabetes Care, Inc.	17	$414
Medtronic(2 entities)	11	$374
Endo Pharmaceuticals Inc.	21	$313
Tolmar, Inc.	14	$243
Zealand Pharma US, Inc.	10	$237
Dexcom, Inc.	12	$226
Ultragenyx Pharmaceutical Inc.	6	$221
Ipsen Biopharmaceuticals, Inc	6	$210
IBSA Pharma Inc.	8	$190
Companion Medical, Inc.	4	$183
Amneal Pharmaceuticals LLC	8	$167
Neurocrine Biosciences, Inc.	6	$158
Ferring Pharmaceuticals Inc.	7	$153
Kyowa Kirin, Inc.	7	$153
Bigfoot Biomedical Inc	1	$152
Lilly USA, LLC	9	$151
Arbor Pharmaceuticals, Inc.	5	$127
Amphastar Pharmaceuticals, Inc.	6	$126
Amryt Pharma Holdings Ltd	2	$126
Biomarin Pharmaceutical Inc.	4	$89
Abbott	4	$75
Kvk-tech, Inc.	1	$75
Rhythm Pharmaceuticals, Inc.	3	$71
Embecta Corp.	3	$64
Sandoz	3	$61
Boehringer Ingelheim	3	$59
Endo USA, Inc.	2	$52
Soleno Therapeutics, Inc.	2	$48
Corcept Therapeutics	2	$42
Amgen	1	$30
BD	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$474,920 in reported general payments places this provider in the 85th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia →

Other pediatric endocrinology in Atlanta

Daniel HsiaAtlanta$1.8M
Eric FelnerAtlanta$1.2M
Malinda WuAtlanta$972K
Kristina CossenAtlanta$310K
Andrew MuirAtlanta$306K
Doris FadojuAtlanta$151K
Lina MerjanehAtlanta$14K
Stephen AndersonAtlanta$1K
Marjorie GolekohAtlanta$808
Rajeev ThirunagariAtlanta$463

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →